Background: The stability limit of an analyte in a biologi cal sample can be defined as the time required until a measured property acquires a bias higher than a defined specification. Many studies assessing stability and pre senting recommendations of stability limits are available, but differences among them are frequent. The aim of this study was to classify and to grade a set of bibliographic
Introduction
Stability is the capability of a sample material to retain the initial property of a measurand for a period of time within specified limits when the sample is stored under defined conditions [1] . The stability is mainly affected by storage time and also by other factors that increase the metabolism of the analyte or cause the initial property to disappear, such as temperature, light exposure, solvent evaporation or stirring.
The change in the property over time can be expressed as percent deviation (PD%) or bias with respect to the initial value, whereas the deterioration can be defined as a function that represents the variation of PD% over time. It can also be graphically represented in a twodimen sional chart with the PD% in the yaxis and the time in the xaxis, similar to the habitual representation of the dose response in relation to an interfering substance. In fact, both interferences and instability in a particular sample are the main components of specimenspecific sistematic error. The stability limit for an analyte is defined as the point in time when the PD% reaches a given specification of maximum allowable error. Similar to doseresponse graphs for interferences, stability limits may also be easily extrapolated from such graphs.
It should be noted that this equation is modified by the physicalchemical factors that facilitate the process of instability, mainly contact with air, temperature, light exposure or agitation. This means that the stability limit needs to be defined for specific conditions (e.g. blood glucose stability in whole blood in closed tube, at room temperature, protected from light and without stirring).
Although a myriad of experimental studies assess ing the stability of most laboratory magnitudes in various conditions may be found in the literature, there are few clinical guidelines with general recommendations for the laboratory. The most widely used is the recommendation of the German Society of Clinical Chemistry (DGKL), published in a WHO report and later updated [1] . These recommen dations are based on the collection of published studies, and separated into two basic conditions of stability; the specimen, as obtained from the patient, and the sample, prepared for analysis. The controversy within this recom mendation is that stability limits of the reviewed studies are directly assumed or arbitrarily summarized. Noticeable aspects affecting this situation are the variability in the methodology and the quality of the studies included (some of them were performed a long time ago, using materials that are nowadays obsolete) and the different criteria to define the degree of deterioration that hamper the estab lishment of a rejection recommendation (maximum allow able error), even though the document includes a specific recommendation for the MAE based on biological variation (half of the total allowable error), included studies use dif ferent criteria, sometimes purely metrological or statistical. This may be due to the absence of clinical guidelines for the design of stability studies in clinical samples, in contrast with other components of total error, such as imprecision, accuracy or interferences. Therefore, the studies pub lished follow different procedures, have variable number of samples, different statistical approaches and different maximum allowable error criteria.
The aim of this study was to classify and to grade a set of bibliographic studies about the stability of five common blood measurands and subsequently generate a consen sus stability function. For this pilot study we selected five magnitudes, four of them with wellknown stability prob lems (glucose, potassium, phosphorus and specific pros tate antigen) and one of them usually mentioned as stable (ALT). These models could help medical laboratories to define stability limits based on their own specifications of maximum allowable error for the preanalytical phase.
Materials and methods

Scientific bibliographic search
The analytes selected for the validation of this method were alanine aminotransferase (ALT), glucose, potas sium, phosphorus and prostatespecific antigen (PSA).
The search strategy in PUBMED included: "(sample OR samples OR specimen OR specimens) AND (stability OR deterioration OR preanalytical OR preanalytical)" in the last 15 years. A total of 1084 entries were obtained.
The acceptable articles were selected by two members of the Committee by checking the abstracts. Acceptability included inclusion of ALT, glucose, potassium, phospho rus or PSA in blood in the study. Fortyeight references were finally included .
Acceptability of bibliographical references
In order to grade the quality of the papers, a checklist was defined including all variables that could affect the stabil ity of selected magnitudes in blood (Table 1) . Every item was rated as 0 if not considered for the study design, 1 if included and 2 if it improved the design. The maximum score was 29 points. References were classified into four grades: excellent if the score was above 21.75 points, acceptable if it was between 14.5 and 21.75 points, doubt ful if between 7.25 and 14.5 points and unacceptable if the score was lower than 7.25 points. Scoring and grading of every reference was performed by the members of the Committee, in pairs. In case of discrepancies in grading, a new revision by another member was performed and an average score was obtained.
Stability conditions
In order to compare the primary data of PD%, it is essential that the different studies have similar experimental condi tions. Hence, a second checklist was prepared to compile the performance conditions of each stability experiment included.
The items included in this checklist were: 1. Strict definition of the system: the sample type (whole blood, serum or plasma) and the container/addi tive used (including manufacturer reference when available 
Results
Fortyeight bibliographical references were selected, 11 of which were discarded as not presenting valid primary data to calculate PD%. In the 37 valid references, up to 130 different experiments were included; 48 in whole blood, 30 in plasma and 52 in serum. Of the five magnitudes assessed, 629 valid stability PD% data were collected: 180 for glucose, 113 for phosphorus, 145 for potassium, 106 for ALT and 85 for PSA (35 for total PSA and 50 for free PSA). Forty data points for glucose stability studies used glyco lysis inhibitors, and were excluded due to the heterogene ity of tube types.
In the 48 peerreviewed references, the average score was 18.3 points (SD 3.83, range 8.0-24.5), and were graded as: three unacceptable, seven doubtful, 28 acceptable and 10 excellent. Only in two cases there was a discrepancy between reviewers, and a third revision was included. The items included in the evaluation checklist are outlined in Table 1 , as well as the percentage of studies found for every condition.
Most studies used healthy subjects (60.4%) instead of patient samples. The typical sample size was between 10 and 30 individuals (45.8%), often with a single determi nation (68%). The procedure of blood collection was fre quently defined (73%) and often appropriate in terms of duration and volume (62.9%). The venipuncture devices were usually commercial and vacuum systems were used (90.5%) which could warrant a controlled contact with air during the experiment. However, in 52% of the references this aspect was not clearly reflected.
Temperature was controlled throughout the process in 87.5% of the references, but not agitation (31%), nor light exposure (27%). Centrifugation conditions, includ ing force and time and sample storage until centrifugation were properly defined in 60.5% and 82.1% of the refer ences, respectively.
Once the stability experiment finished, samples were analyzed immediately or deepfrozen to be processed in batch (95.3%). The analytical methods were correctly defined in 85% of the references, although the quality assurance of the process was not mentioned in one third of cases (31.8%). The confidence interval for PD% was lacking in 30.5% of the articles. Moreover, 27% of the studies did not perform any analysis of the differences.
Maximum allowable difference specifications were based on biological variation in 17 studies, on metrological criteria in 12 studies and exclusively statistical in 13 studies.
Twelve studies did not include any kind of data regarding PD% for their magnitudes, neither graphs that Description of the variables that affect the stability and scores for each, together with the percentage of studies for every item.
allowed an estimate, therefore they were excluded from stability models [7, 11, 14, 22, 27-29, 41, 44, 46-48] .
With regard to stability conditions 1 . Strict definition of the system. Thirteen different con ditions were defined, including 57 studies in whole blood, 51 in serum and 22 in plasma. In the whole blood studies, seven different conditions were con sidered (without additives 5, EDTA 4, heparin 12, with glycolysis inhibitors 16, nonthrombin procoagulant and gel 15, nonthrombin procoagulant without gel 4, and with thrombin procoagulant 1). In the serum studies, two conditions were suggested; nonthrom bin procoagulant (49 studies) or thrombin procoagu lant (two studies). In the plasma studies there were 16 with heparin, two with glycolysis inhibitors and one with EDTA. Due to the great variety of conditions, we moved to a basic classification in two types; whole blood vs serum/plasma. The great difference between these conditions is cell contact, which is complete in whole blood, and reduced to the presence of residual cells in serum or plasma. Studies using a glycolysis inhibitor were separated in the case of glucose. 2. Blood collection procedure. The most frequent design was the collection in primary tubes and used directly for analysis (74 studies, 57%). In 39 studies, collec tion was performed in the primary tube, but an ali quot was used to perform the analysis. In seven cases, the drawn tubes were mixed to prepare a pool and in seven cases all the necessary volume was collected in a different device and secondary tubes were prepared for the stability study. Blood collection procedure was not defined in three cases. 3. Temperature of collection and storage. Regarding the collecting temperature, the great majority of stud ies (118) were carried out at room temperature. With respect to storage, temperature was usually controlled in a narrow range, according to its influence on sta bility. The most studied temperatures were 4 °C (28 experiments), 22 °C (32 experiments) and 27 °C (14 experiments), although many studies used other tem peratures. A basic classification was set as refrigerated (range 4-9 °C) or room temperature (RT) (15-27 °C). 4. Light exposure. As already mentioned as a quality parameter, only 22 experiments specified protection from light during the period assessed. 5. Stirring. It was only controlled in 16 studies. 6. Evaporation. In four studies, the effect of evaporation was studied (open tube), in 58 studies the tubes were kept capped to avoid evaporation and in 68 studies it was not specified. 7. Batch analysis. One hundred and one studies were analyzed in several batches and 29 in a single batch. Studies made in a single batch are less prone to impre cision, but need an extra storage time that could bias the results. 8. Sample storage until analysis. In 29 single batch stud ies, samples needed to be stored until batch analysis, usually frozen or deepfrozen storage [16] , however, 14 were refrigerated. 9. Laboratory instrumentation/Analytical methodology.
More than 50 different instruments and a great variety of methods were registered.
Stability models in basic conditions
With the PD% data collected from the studies, a scatter gram of PD% over time expressed in hours was prepared.
A regression was made using least squares and the sig nificance and strength of the adjustment were verified. We evaluated the points obtained under similar stabil ity conditions for each magnitude. Initially, only sample type (whole blood versus serum/plasma) and the most common temperatures (room and refrigerated) were considered. Table 2 shows the number of references and points included, the goodness of fit (Pearson's r for each model), the statistical significance (pvalue) and the selected equation. Glucose stability depends mainly on cell contact. The uptake and metabolism depend on the activity of the glycolytic enzymes, which explains why refrigeration is commonly used as a preservation method [51] . In whole blood, there is a decrease of approximately 1%/h at room temperature and 0.3%/h in whole refrigerated blood. In both cases, the equation that best adjusts is a quadratic model although the linear model could also be consid ered as acceptable (Figure 1 ). There is a clear increase in the rate of degradation with temperature that can be verified including the quantitative variable in a multiple regression model where both factors are significant (coef ficient for time: B = − 0.6%/h, temperature: B = −1.6%/°C). Although the average equation obtained shows a slope of 1%/h, studies at temperatures around 20 °C are close to 2%/h. Studies of accelerated degradation at 30-37 °C yield a decrease approaching 4%/h (Figure 2 ). Degradation is also observed in serum/plasma, with no marked effect on temperature. The decrease is around 0.1%/h.
The case of phosphorus is compelling; only a clear stability loss in whole blood at room temperature is observed. In refrigerated whole blood, a very slight eleva tion was observed (0.2%/h). Serum and plasma produced an even lower elevation of 0.07%/h and 0.03%/h at room temperature and refrigerated, respectively. In the case of whole blood at room temperature, the adjustment by a cubic model significantly improved the linear adjustment due to a different behavior in the first 24 h and in the later time points. There is an initial period of up to 12-18 h in which the phosphorus decreased (possibly explained by entry into the red blood cells), from 18 to 24 h phospho rus increased exponentially, rising to 400% in 2-3 days (probably by degradation of the phosphate esters) [2, 3] ( Figure 3 ). For potassium, a temperaturedependent behavior was observed, similar to glucose, but in the opposite direc tion. In refrigerated whole blood, it undergoes a greater increase of approximately 3%/h, which is clearly observed in the first hour of storage. Nevertheless, at room tem perature, no significant modification was seen in the first 24 h. After 24 h, the function changes to a linear increase similar to that observed in the refrigerated samples. This behavior also seems to occur in serum/plasma at room temperature, however, a clear increase in the refrigerated sample was not observed, with a weaker adjustment of the equation (r <0.7) (Figure 4 ).
For ALT, there are some studies indicating an increase and others indicating a decrease in both whole blood and serum/plasma. Only in the case of whole blood at room temperature a significant regression line may be estimated, with a weak fit (r = 0.3), in the rest of conditions it was not possible to adopt a consensus equation (Figure 5 ).
For free PSA, a very similar decrease in serum/ whole blood was observed in both refrigeration and room temperature. It could even be simplified in a single model with a decrease of 0.25%/h. This was sig nificant in all cases with an acceptable linear model. In the case of PSA, there were few studies, with no appar ent loss of stability over time. A significant adjustment was not achieved except in the serum/plasma sample at room temperature, where there was a slight decrease of 0.04%/h ( Figure 6 ). These functions can be used to define stability limits applying several specifications for maximum allowable error. For glucose, when considering very demanding specifications (desirable sistematic error based on biologi cal variation 2.34% [52]) or mild specifications (minimum consensus specifications from Spain 12% [53] ) the stability limit would range between 2 and 13 h in whole blood at RT and between 22 and 111 h in refrigerated serum (Table 3) .
Discussion
In laboratory medicine, traceability of the preanalytical phase is essential. Two critical aspects are the storage temperature and the time from sample collection until its processing. The loss of stability is likely to involve an unacceptable error in the result of a measured component that may lead to wrong clinical decisions. That is why laboratories should define stability limits for each analyte and sample, and use them as a cause of rejection before processing the sample, in spite of no apparent visible deterioration [54] .
In this study we considered the possibility of using the cummulative information from multiple studies to generate a consensus function of stability in specific situ ations of stability for some magnitudes with known stabil ity problems. Four of the selected analytes to validate this method were well known to be stabilityaffected; glucose, potassium, phosphorus and PSA and one analyte with doubts about stability (ALT).
The first step was to grade the quality of the stabil ity studies. The quality of the published stability studies with the designed checklist is acceptable/excellent in the majority of cases (80%), although some usual defects were detected. A high percentage of studies did not con sider essential variables such as evaporation (52%), light exposure (73%), or agitation (69%). In the design of the checklist, it was originally thought to consider the absence of control of these variables as a reason for direct rejection of the study, as well as the absence of statisti cal study. We observed later that the main problem was the absence of primary data and this frequently concurred with low quality articles. In 11 of 48 studies (23%) no usable primary data were available, neither in table nor in figure form. This prevents the results from being con firmed by other studies. Rejected studies included the three ones classified as unacceptable.
A possible explanation to this variability is the absence of guidelines or recommendations regarding the way a stability study should be carried out. An agreement on the metric to be used is the minimum deemed nec cesary. When dealing with a systematic error, it would be reasonable to use the percent deviation in relation to time, as recommended by the German Society of Clinical Chemistry [1] or by CLSI for reagent estability [55] . In our nonexhaustive literature review, data were col lected from about four to eight studies for each minimum study condition (specimen and temperature), with an average of 10-30 points for each model. With this number of studies we achieved reliable consensus functions in most of the magnitudes with a reasonable statistical con fidence in the model. In the magnitudes studied, it was possible to define a basic model (whole blood and serum at room temperature or refrigerated) that could cover general working conditions in four of them including PSA, in spite of the low number of studies included. For ALT it was not possible due to the heterogeneity of the results. This magnitude was selected because its instability was only occasionally mentioned. This approach seems inef fective in defining any small loss of stability that should be demonstrated by conclusive experimental studies.
In the case of phosphorus, if strict specifications are applied (desirable systematic error, 3.4%) stability is lost in the first 3 h due to the initial decrease. However, with more extensive specifications, (desirable total error 10%; minimum consesus specification 16%) there would be no loss of stability until 16-18 h, during the second phase of increase. In fact, some authors have reported 3 h stability for phosphate [13, 39] , while others have described 24 and even 72 h [2, 3, 24, 26, 49] .
In the case of potassium, contradictory results were obtained. In serum, the stability is lower at room tem perature than refrigerated, conversely as occurs in whole blood. The theoretical mechanism of onset of potassium is the output of intracellular content that should be depend ent on the number of residual cells (greater in plasma than in serum) and dependent on the same manner of inactiva tion of ATPase by cold [56] . It is very likely that the way of preparation and separation in the experiments is a very important factor to consider in their comparability.
For glucose, contact with cells and temperature were well known factors of instability. In whole blood a differ ence of 5-10 °C could double the loss of stability. However, the definition of maximum allowable error could be the main factor that justifies the differences in published stability limits.
The stability limit for a magnitude depends on the storage conditions defined by the laboratory, but also largely on the specifications that are selected to define the maximum alowable error.
The usual definition of total analytical error (TAE) does not include components of systematic error due to the sample, which considers the effect of stability loss or deterioration by in vitro hemolysis, among others [57] . The design of all laboratory methods includes the selection of the most appropriate specimen/sample and the accept ability conditions of the sample, which usually appear as a rule of thumb; "stable in whole blood with EDTA for 8 h...", however, it is widely known that deterioration is usually a continuous function over time, depending on the physicalchemical conditions of the sample. For blood samples, time, temperature, contact with atmospheric air, or light exposure and agitation can substantially modify the deterioration function in a predictable amount if com plete traceability of preanalitical phase were avalaible. Consensus statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine stated "it is acknowledged that, for patient care, optimizing the quality of the total (preana lytical/analytical/postanalytical) examination process is the ultimate goal and therefore it would be desirable to go beyond setting analytical performance specifications and to establish examination performance. In principle, the performance specifications for the pre and postanalyti cal laboratory processes should follow the models as for analytical performance specifications. When components of these additional phases can be expressed in numerical terms, they should be added in defining examination per formance specifications" [58] .
We found that in many cases the adjustment of the stability curves is not linear, even in the case of phospho rus a biphasic behavior was detected. It is important to note that in clinical samples there may be multiple simul taneous effects that could provoke unexpected responses in stability of clinical samples.
As limitations of this study it is necessary to empha size the nonexhaustive nature of the bibliographical search. The aim was to test a strategy of unification of results that has only been possible to verify in magnitudes with known problems of stability and for basic conditions. There are likely to be many more stability studies that could expand and improve the model. In the case of ALT, which we chose as an example of magnitude considered stable although a decrease in enzymatic activity would be expected over time, the results of the studies are very discordant despite being considered of adequate quality. For these cases, new studies would be necessary, which should be carried out ideally contemplating all the possi ble variables and a standardized design. The development of an international guide on stability testing would be very useful for the future comparability of these studies.
In conclusion, we propose a quality graduation and unification tool of stability studies on literature that could be useful to define a consensus stability function in spe cific conditions that could help laboratories to define sta bility limits using their own quality specifications.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
